Novanta is trading 4.07% down now at $128.85 in pre-market, with no clear company-specific announcement surfaced for September 22, 2026.
- The latest identifiable catalyst was its August 6, 2026 second-quarter earnings beat and raised outlook, which is stale and does not directly explain the decline.
- The broader market is mixed rather than sharply risk-off; the move remains unexplained and may warrant re-checking for delayed news.
- Recent commentary remains broadly positive on Novanta’s growth profile.